Search results
Results from the WOW.Com Content Network
This is the first study that shows antibiotics [are] independent of changing the biome and microbiome of the gut by changing the cells of the gut independent of bacteria, which is [a] completely ...
Narrow-spectrum antibiotics have low propensity to induce bacterial resistance and are less likely to disrupt the microbiome (normal microflora). [3] On the other hand, indiscriminate use of broad-spectrum antibiotics may not only induce the development of bacterial resistance and promote the emergency of multidrug-resistant organisms, but also cause off-target effects due to dysbiosis.
Skin damage; Antibiotic treatment leading to disruption of the physiological microbiome, thus allowing some microorganisms to outcompete others and become pathogenic (e.g. disruption of intestinal microbiota may lead to Clostridium difficile infection) Medical procedures; Pregnancy
Lactic acid bacteria (LAB), which are food fermenting bacteria, have the ability to prevent food spoilage and can improve the nutritive value of the foods they inhabit. Acid fermentation (as well as salting), remains one of the most practical methods of preservation of fresh vegetables, cereal gruels, and milk-cereal mixtures due to its low ...
In 2011, Pfizer, one of the last major pharmaceutical companies developing new antibiotics, shut down its primary research effort, citing poor shareholder returns relative to drugs for chronic illnesses. [248] However, small and medium-sized pharmaceutical companies are still active in antibiotic drug research.
The BMC Series is a collection of several dozen online research journals published by BioMed Central. [9] Like all other BioMed Central journals, they have a policy of open access to the research articles they publish. Between them, they cover all major subject areas within biology and medicine.
The Human Microbiome Project (HMP) was a United States National Institutes of Health (NIH) research initiative to improve understanding of the microbiota involved in human health and disease. Launched in 2007, [ 1 ] the first phase (HMP1) focused on identifying and characterizing human microbiota.
The Journal of Antibiotics is a peer-reviewed medical journal published by the Nature Publishing Group for the Japan Antibiotics Research Association. The journal seeks to endorse studies on antibiotics and associated types of biologically-active substances. In June 2020, the journal published a pioneer systematic review on ivermectin and COVID ...